Symbiotic and Midas have partnered to address the liquidity challenges plaguing tokenized assets. The collaboration leverages Symbiotic Core V2 and Midas' Open Liquidity Architecture to introduce an RFQ-based settlement layer enabling T+0 atomic settlements without pre-funded inventory or idle capital buffers.

Tokenized assets, despite their promise of democratized access, often suffer from crippling illiquidity. Redemption timelines stretching 60-180 days freeze capital and undermine utility. The new solution targets this pain point directly—market makers respond to onchain RFQs with competitive bids, executing settlements in single transactions while earning spreads.

The system already supports Midas-listed assets including Fasanara's mGLOBAL fund. By eliminating capital inefficiencies, the partnership creates a blueprint for scalable RWA liquidity that could accelerate institutional adoption of blockchain-based asset representation.